ArticleFrontiers in pediatrics2026

Neoadjuvant therapy with anlotinib in a 5-year-old child with advanced papillary thyroid carcinoma: a case report.

Yuan Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.